226 related articles for article (PubMed ID: 30969158)
21. RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers.
Boleij A; Tops BB; Rombout PD; Dequeker EM; Ligtenberg MJ; van Krieken JH;
Oncotarget; 2015 Jun; 6(17):15681-9. PubMed ID: 25944693
[TBL] [Abstract][Full Text] [Related]
22. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.
Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A
Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074
[TBL] [Abstract][Full Text] [Related]
23. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
24. Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing.
Nkosi D; Casler VL; Syposs CR; Oltvai ZN
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627184
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.
Xu X; Yang Y; Li H; Chen Z; Jiang G; Fei K
Scand J Clin Lab Invest; 2016 Sep; 76(5):386-92. PubMed ID: 27215271
[TBL] [Abstract][Full Text] [Related]
26. Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.
Davies KD; Farooqi MS; Gruidl M; Hill CE; Woolworth-Hirschhorn J; Jones H; Jones KL; Magliocco A; Mitui M; O'Neill PH; O'Rourke R; Patel NM; Qin D; Ramos E; Rossi MR; Schneider TM; Smith GH; Zhang L; Park JY; Aisner DL
J Mol Diagn; 2016 Jul; 18(4):572-9. PubMed ID: 27155050
[TBL] [Abstract][Full Text] [Related]
27. Implementation, Evolution, and Laboratory Performance of Methods-Based Proficiency Testing for Next-Generation Sequencing Detection of Germline Sequence Variants.
Tsuchiya KD; Funke B; Hegde M; Santani A; Souers RJ; Szelinger S; Halley J; Zhao Q; Mot N; Roy A; Smith VL; Zhang BM; Voelkerding K; Moyer AM
Arch Pathol Lab Med; 2024 Jul; 148(7):775-783. PubMed ID: 37852169
[TBL] [Abstract][Full Text] [Related]
28. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
[TBL] [Abstract][Full Text] [Related]
29. [Molecular biological diagnostics of KRAS and BRAF mutations in patients with colorectal cancer - laboratory experience].
Robešová B; Bajerová M; Vašíková A; Ostřížková L; Hausnerová J; Kyclová J; Pospíšilová S; Mayer J; Dvořáková D
Klin Onkol; 2013; 26(1):25-30. PubMed ID: 23528169
[TBL] [Abstract][Full Text] [Related]
30. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
Franczak C; Dubouis L; Gilson P; Husson M; Rouyer M; Demange J; Leroux A; Merlin JL; Harlé A
PLoS One; 2019; 14(2):e0212801. PubMed ID: 30811471
[TBL] [Abstract][Full Text] [Related]
31. RNA Sequencing for Solid Tumor Fusion Gene Detection: Proficiency Testing Practice and Performance Comparison.
Bridge JA; Halling KC; Moncur JT; Souers RJ; Hameed MR; Fernandes H; Roy A; Surrey L; Tafe LJ; Vasalos P; Lopez-Terrada DH
Arch Pathol Lab Med; 2024 May; 148(5):538-544. PubMed ID: 37535666
[TBL] [Abstract][Full Text] [Related]
32. Economic analysis of BRAF gene mutation testing in real world practice using claims data: costs of single gene versus panel tests in patients with lung cancer.
Dalal AA; Guerin A; Mutebi A; Culver KW
J Med Econ; 2018 Jul; 21(7):649-655. PubMed ID: 29516752
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Traditional and Reverse-Algorithm Syphilis Screening in Laboratory Practice: A Survey of Participants in the College of American Pathologists Syphilis Serology Proficiency Testing Program.
Rhoads DD; Genzen JR; Bashleben CP; Faix JD; Ansari MQ
Arch Pathol Lab Med; 2017 Jan; 141(1):93-97. PubMed ID: 27763779
[TBL] [Abstract][Full Text] [Related]
34. Somatic mutations and immune checkpoint biomarkers.
Parris BA; Shaw E; Pang B; Soong R; Fong K; Soo RA
Respirology; 2019 Mar; 24(3):215-226. PubMed ID: 30636374
[TBL] [Abstract][Full Text] [Related]
35. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
Gailey MP; Stence AA; Jensen CS; Ma D
Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
[TBL] [Abstract][Full Text] [Related]
36. College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis.
Brothman AR; Dolan MM; Goodman BK; Park JP; Persons DL; Saxe DF; Tepperberg JH; Tsuchiya KD; Van Dyke DL; Wilson KS; Wolff DJ; Theil KS
Genet Med; 2011 Sep; 13(9):765-9. PubMed ID: 21633292
[TBL] [Abstract][Full Text] [Related]
37. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
38. Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies.
Keegan A; Bridge JA; Lindeman NI; Long TA; Merker JD; Moncur JT; Montgomery ND; Nagarajan R; Rothberg PG; Routbort MJ; Vasalos P; Xian R; Kim AS
Arch Pathol Lab Med; 2020 Jan; ():. PubMed ID: 31986076
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys.
Lyon E; Schrijver I; Weck KE; Ferreira-Gonzalez A; Richards CS; Palomaki GE;
Genet Med; 2015 Mar; 17(3):219-25. PubMed ID: 25077647
[TBL] [Abstract][Full Text] [Related]
40. EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.
Thunnissen E; Bovée JV; Bruinsma H; van den Brule AJ; Dinjens W; Heideman DA; Meulemans E; Nederlof P; van Noesel C; Prinsen CF; Scheidel K; van de Ven PM; de Weger R; Schuuring E; Ligtenberg M
J Clin Pathol; 2011 Oct; 64(10):884-92. PubMed ID: 21947301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
